Steroids and related studies: Part 88-3-(2-dialkylaminoethoxy)-17α-methyl-17α-aza-d-homo-1,3,5(10)-estratriene dimethiodides
摘要:
Three of the title compounds 15, 16 and 17 were prepared as potential neuromuscular blocking agents. Structurally these partly resemble clinically active chandonium iodide (1). In the in vivo tests, all three compounds were less active than chandonium; however, compounds 16 and 17 were more active in in vitro testings. While preparing the bisquaternary compounds, different steroidal amines were obtained, the hydrochlorides of which when tested showed no significant antiarrhythmic activity.
Steroids and related studies: Part 88-3-(2-dialkylaminoethoxy)-17α-methyl-17α-aza-d-homo-1,3,5(10)-estratriene dimethiodides
摘要:
Three of the title compounds 15, 16 and 17 were prepared as potential neuromuscular blocking agents. Structurally these partly resemble clinically active chandonium iodide (1). In the in vivo tests, all three compounds were less active than chandonium; however, compounds 16 and 17 were more active in in vitro testings. While preparing the bisquaternary compounds, different steroidal amines were obtained, the hydrochlorides of which when tested showed no significant antiarrhythmic activity.
Three of the title compounds 15, 16 and 17 were prepared as potential neuromuscular blocking agents. Structurally these partly resemble clinically active chandonium iodide (1). In the in vivo tests, all three compounds were less active than chandonium; however, compounds 16 and 17 were more active in in vitro testings. While preparing the bisquaternary compounds, different steroidal amines were obtained, the hydrochlorides of which when tested showed no significant antiarrhythmic activity.